Observations in 205 patients with cardiovascular manifestations of anaphylactic shock confirmed the belief that adrenaline is the drug of first choice in management and that colloid solutions are preferable to crystalloid solutions in volume replacement. Arrhythmias and elevated filling pressures are more common in patients with cardiac disease but the sympathetic response appears to override the cardiac effects of histamine in healthy patients.
The rapid onset, priority of treatment and usual rapid response to therapy in anaphylactic shock have precluded the performance of detailed haemodynamic studies which have elucidated the pathophysiology of other forms of shock. Animal studies of anaphylactic shock may be misleading as the animal response usually involves a single organ, the target organ, whereas in man multiple organs are usually involved. Further, the inherent variation in severity of the response, underlying health of patient, time of intervention and diagnosis provide variables which influence both the clinical features and response to treatment.
The increasing incidence of anaphylactoid reactions occurring in operating rooms l has provided a good opportunity to observe the clinical features of the reactions and to enable some assessment of treatment. While this approach is inherently anecdotal, the acquisition of a large series of patients has enabled some repeated features of the pathophysiology and treatment to be documented.
MATERIAL AND METHOD
Over a ten-year period, 227 patients or histories were referred to the author after severe reactions clinically resembling anaphylaxis and related to anaesthesia. The criteria for selection have been published previously. 2 In all cases, the anaesthetist was asked to provide details and timing of features observed and treatment given as accurately and as soon as possible after the event.
In twenty-two patients, measurements of haemoglobin levels were obtained preoperatively and at various time intervals during the reaction.
RESULTS
Cardiovascular collapse defined as systolic blood pressure below 40 mmHg was the most common feature of the reactions, occurring in 205 patients. It was the most severe clinical feature in 155 patients and the sole manifestation of clinical anaphylaxis in twelve. In eighty-three patients, the blood pressure was described as unrecordable at some stage during the reaction. In 192 patients, vasodilation was initially noticed and vasoconstriction in ten patients. In sixty patients, the blood pressure was restored to pre-operative values in the absence of inotropic drugs within twenty minutes, and in four patients continuous infusion of an inotrope was necessary for longer than 24 hours. The changes in cardiac rhythm noted in 186 patients are shown in Table 1 . Supraventricular tachycardia (SVT) was the most common arrhythmia and four patients developed ventricular fibrillation following SVT. In all four patients, this was associated with the use of intravenous adrenaline boluses and halothane. The three patients who were on beta-blockers orally prior to anaesthesia and the one patient who received intravenous betablockers prior to induction developed bradycardia, and transient bradycardia prior to SVT was observed in six patients. SVT was associated with ST elevation in eight patients, six of whom had no history of cardiac disease. It was not associated with any post-reaction evidence of ischaemic damage. Table 2 shows the incidence of arrhythmias comparing patients with and without cardiac disease and demonstrates that in the absence of cardiac disease, arrhythmias other than SVT are uncommon while the converse is true for patients with cardiac disease. The patients without cardiac disease who develop other arrhythmias include three who developed ventricular fibrillation in the presence of halothane and adrenaline, two who had bradycardia after beta-blockers, three with SVT following transient bradycardia, and one arrested in asystole after prolonged hypoxia. This patient died. In spite of eighty-three patients being described as pulseless, only twenty-eight received cardiac massage. Cardiac filling pressures were measured in forty-six patients during resuscitation. Rightsided pressures (CVP) alone were measured in forty patients and left-sided pressures (PCWP) and CVP in six patients. In the six patients who had left-and right-sided pressures, measured balloon catheters were in situ at the time of the reaction. Four patients had central venous lines in at the time of the reaction and in the other thirty-six patients the CVP line was inserted during resuscitation, between ten and seventyfive minutes after the reaction. CVP was low in all patients without cardiac disease (37), and PCWP was low in three. In patients with known cardiac disease, CVP was elevated in nine and low in two, and PCWP elevated in three. In six of nine, volume expansion was required to achieve a stable blood pressure in spite of initial raised filling pressures. In all six patients with balloon catheters, pulmonary artery pressure rose initially and fell over ten minutes.
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Volume of colloid infusion prior 10 measurement of serum haemoglobin level V 2
Volume of crystalloid infusion Hb 2
Second haemoglobin measurement g/I T, Time of second haemoglobin measurement from induction of anaesthesia (minutes) V3
Volume of colloid infusion prior to measurement of third haemoglobin measurement V 4 Volume of crystalloid prior 10 measurement of third haemoglobin measurement Hb 3
Third haemoglobin measurement g/l T2
Time of third haemoglobin measurement (minutes) need for inotropic support (seven patients) or both (six patients). The one patient who had clinically normal perfusion with a haemoglobin of 168 grams/litre had received H I and H2 antihistamines late in resuscitation. The use of sympathomimetic drugs is shown in Table 4 . Adrenaline was the most effective inotrope when used as first-line therapy. Although dopamine was effective in all patients who received it, it was used late by infusion after an initial response to bolus adrenaline. Three patients who did not respond to adrenaline died, and two patients who were hypotensive after adequate fluid therapy and adrenaline infusion responded dramatically to noradrenaline.
There was no evidence of any immediate response to steroids or H I antihistamines but two patients were rapidly weaned from adrenaline infusions after a combination of cimetidine 200 mg and promethazine 25 mg.
Twelve patients received frusemide for anuria and no patient exhibited a diuretic response within forty-five minutes. In eight of these patients, colloid solutions given to restore haemoglobin to normal in association with decreasing infusion of adrenaline led to a brisk diuresis.
In the seven fatal cases in the series of 227, one patient had severe cardiac disease and was shown at post mortem to have massive infarction. In the other six, cardiovascular collapse occurred and adrenaline was given late in the course of treatment in all cases.
DISCUSSION
In the absence of an ability to perform controlled trials of therapy on the management of anaphylactoid cardiovascular collapse, three approaches are possible. The first is to extrapolate to the human information available about the known mediators released, their interaction with receptors, and consequent effects on organ systems, and to use drugs which block, antagonise or reverse these features. This approach has been used to quantify treatment, but has a fundamental defect in that it ignores the important modifying effects of the corticoadrenal system on the response.
The second approach is to extrapolate from animal data. The defects in this approach are related to the suitability of models. Most animals respond through a single-organ system, the shock organ or target organ, unlike the varied multisystem response of man, and the response may be both mechanism-dependent or related to different mediators. 4 However, the observations made in these patients suggest that the response is similar to that of the monkey.
The analysis of a large series of cases is more fallible in methodology than either of the previous approaches. The accuracy of the observations in a time of intervention and stress is questionable, and the ability to assess the effects of a single intervention when numerous interventions occur is difficult. However, a number of simple conclusions can be drawn which correlate with the theories based on mediator release and are of practical value.
The cardiovascular collapse is primarily caused by vasodilation and fluid loss. In spite of the presence of histamine receptors in the heartS and arrhythmogenic effects of histamine in vitro,6 arrhythmias and cardiac failure were not a problem in patients without cardiac disease in this series. Although with minor reactions due to direct histamine release heart rate correlates with histamine levels 7 and histamine release may adversely affect the diseased heart,8 the tachycardia of severe anaphylactoid reactions in fit patients is likely to be benign and is related to the release of endogenous catecholamines rather than vasoactive mediators. 9 This is further supported by the failure of beta-blocked patients to develop tachycardia. The failure to institute cardiac massage is interesting and probably related to the association of the hypotension with relatively benign rhythms. It should be emphasised that the decision to institute external cardiac massage (ECM) should be based on flow rather than electrical activity of the heart, although the limited value of such massage in the presence of a volume deficit must be appreciated.
Adrenaline is the drug most likely to be effective. It should be infused into monitored patients, and particular caution should be exercised if halothane has been used. When adrenaline and adequate volume do not produce improvement, noradrenaline may be life-saving.
Although some patients may be resuscitated quickly with vasoconstrictors and crystalloid, the majority of patients with severe reactions have a significant volume deficit which is much more effectively treated with colloid solutions.
Patients with cardiac disease may show elevated filling pressures in the presence of a volume deficit and require particularly careful assessment.
Most articles on anaphylaxis state that antihistamines are of no benefit. In two patients in this series, there appeared to be improvement when HI and H2 blockers were administered late in the reaction. This observation has been made by others in a small number of cases (J. Moss, personal communication) . At present all that can be said of this form of therapy is that it is worthy of trial if anaphylaxis is prolonged, but it is not possible to show beneficial effects of HI antihistamines in the early management. A similar situation exists for corticosteroids, although their use is theoretically indicated in anaphylactic bronchospasm.
